ArticleTherapeutic advances in neurological disorders2019

Severe rebound after cessation of fingolimod treated with ocrelizumab with coincidental transient aggravation: report of two cases.

Stephan Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.